Skip to main content

Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors

Purinergic Signalling volume 15, pages 367–374 (2019)Cite this article

Abstract

The primary malignancy of liver, known as hepatocellular carcinoma (HCC), comprises 9% of all hepatobiliary carcinomas. A steady rise has also been observed in adenocarcinoma (ADC) of the liver and ampullary carcinoma (AMC), ascending to 0.5% of gastrointestinal malignancies. Hepatobiliary carcinomas consist of 13% of all cancer occurrences worldwide. Purinergic receptor–based signaling holds the therapeutic potential based on its role in cell proliferation of several carcinomas. An altered ATP concentration in nanomoles may lead towards crucial changes in cancer growth patterns in liver tissue. A total of 40 tissue samples were collected (20 samples of HCC, 10 samples of ADC, and 10 samples of AMC) from patients that underwent surgery. P2X4 and P2X7 receptors exhibited significantly increased expression in HCC, ADC, and AMC samples as compared with the control tissue samples. While ADC and AMC samples showed higher expression of P2X4 and P2X7 than the control, statistically, HCC samples exhibited the most significant expression of both P2X4 and P2X7 receptors than control tissues. It may be inferred that higher expression of P2X4 and P2X7 receptors is significantly associated with the upregulated cellular stress leading to inflammation and it is plausible that both these receptors may be used in diagnostic, prognostic, and therapeutic tools for carcinoma studies in the future.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193

    Article  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30

    Article  PubMed  Google Scholar 

  3. Teng Y, Radde BN, Litchfield LM, Ivanova MM, Prough RA, Clark BJ, Doll MA, Hein DW, Klinge CM (2015) Dehydroepiandrosterone activation of G-protein-coupled estrogen receptor rapidly stimulates microRNA-21 transcription in human hepatocellular carcinoma cells. J Biol Chem 290(25):15799–15811

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hafeez Bhatti AB, Dar FS, Waheed A, Shafique K, Sultan F, Shah NH (2016) Hepatocellular carcinoma in Pakistan: national trends and global perspective. Gastroenterol Res Pract 2016:1–10

    Article  Google Scholar 

  5. Burnstock G (2006) Purinergic signalling. Br J Pharmacol 147(S1)

  6. Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134(5):703–707

    Article  CAS  PubMed  Google Scholar 

  7. Di Virgilio F (2012) Purines, purinergic receptors, and cancer. Cancer Res 72(21):5441–5447

    Article  CAS  Google Scholar 

  8. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A, Buell G (1994) A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371(6497):516–519

    Article  CAS  PubMed  Google Scholar 

  9. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Balkwill F, Coussens LM (2004) Cancer: an inflammatory link. Nature 431(7007):405–406

    Article  CAS  PubMed  Google Scholar 

  11. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436–444

    Article  CAS  Google Scholar 

  12. Gonzales E, Prigent S, Abou-Lovergne A, Boucherie S, Tordjmann T, Jacquemin E, Combettes L (2007) Rat hepatocytes express functional P2X receptors. FEBS Lett 581(17):3260–3266

    Article  CAS  PubMed  Google Scholar 

  13. Emmett DS, Feranchak A, Kilic G, Puljak L, Miller B, Dolovcak S, McWilliams R, Doctor RB, Fitz JG (2008) Characterization of ionotrophic purinergic receptors in hepatocytes. Hepatology 47(2):698–705

    Article  CAS  PubMed  Google Scholar 

  14. Dixit A, George J, Cheema H, Ryu Y, Dudeja V, Dawra R, Saluja A (2017) Extracellular ATP promotes systemic inflammation during acute pancreatitis. Gastroenterology 152(5):S896

    Article  Google Scholar 

  15. Greve A-S, Skals M, Fagerberg SK, Tonnus W, Ellermann-Eriksen S, Evans RJ, Linkermann A, Praetorius HA (2017) P2X1, P2X4, and P2X7 receptor knock out mice expose differential outcome of sepsis induced by α-haemolysin producing Escherichia coli. Front Cell Infect Microbiol 7

  16. Draganov D, Gopalakrishna-Pillai S, Chen Y-R, Zuckerman N, Moeller S, Wang C, Ann D, Lee PP (2015) Modulation of P2X4/P2X7/Pannexin-1 sensitivity to extracellular ATP via ivermectin induces a non-apoptotic and inflammatory form of cancer cell death. Sci Rep 5:16222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Khalid M, Brisson L, Tariq M, Hao Y, Guibon R, Fromont G, Mortadza SAS, Mousawi F, Manzoor S, Roger S (2017) Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells. Oncotarget 8(23):37278–37290

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kawano A, Tsukimoto M, Mori D, Noguchi T, Harada H, Takenouchi T, Kitani H, Kojima S (2012) Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages. Biochem Biophys Res Commun 420(1):102–107

    Article  CAS  PubMed  Google Scholar 

  19. Vázquez-Villoldo N, Domercq M, Martín A, Llop J, Gómez-Vallejo V, Matute C (2014) P2X4 receptors control the fate and survival of activated microglia. Glia 62(2):171–184

    Article  PubMed  Google Scholar 

  20. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM, Brissette W, Wicks JR, Audoly L, Gabel CA (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168(12):6436–6445

    Article  CAS  PubMed  Google Scholar 

  21. Li F, Guo N, Ma Y, Ning B, Wang Y, Kou L (2014) Inhibition of P2X4 suppresses joint inflammation and damage in collagen-induced arthritis. Inflammation 37(1):146–153

    Article  CAS  PubMed  Google Scholar 

  22. Di Virgilio F, Ferrari D, Adinolfi E (2009) P2X7: a growth-promoting receptor—implications for cancer. Purinergic Signalling 5(2):251–256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Sluyter R, Barden JA, Wiley JS (2001) Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 304(2):231–236

    Article  CAS  PubMed  Google Scholar 

  24. Li X, Qi X, Zhou L, Catera D, Rote NS, Potashkin J, Abdul-Karim FW, Gorodeski GI (2007) Decreased expression of P2X 7 in endometrial epithelial pre-cancerous and cancer cells. Gynecol Oncol 106(1):233–243

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36(3):293–303

    Article  CAS  Google Scholar 

  26. Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58(1):58–86

    Article  CAS  PubMed  Google Scholar 

  27. Stagg J, Smyth M (2010) Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29(39):5346–5358

    Article  CAS  PubMed  Google Scholar 

  28. Besnard A, Gautherot J, Julien B, Tebbi A, Garcin I, Doignon I, Péan N, Gonzales E, Cassio D, Grosse B (2016) The P2X4 purinergic receptor impacts liver regeneration after partial hepatectomy in mice through the regulation of biliary homeostasis. Hepatology 64(3):941–953

    Article  CAS  PubMed  Google Scholar 

  29. Azimi I, Beilby H, Davis FM, Marcial DL, Kenny PA, Thompson EW, Roberts-Thomson SJ, Monteith GR (2016) Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells. Mol Oncol 10(1):166–178

    Article  CAS  PubMed  Google Scholar 

  30. Markwardt F, Schneider M, Prudic K, Pippel A, Klapperstück M, Müller C, Stolz M, Schumacher M, Schmalzing G (2017) Interaction of purinergic P2X4 and P2X7 receptor subunits. Biophys J 112(3):421a

    Article  Google Scholar 

  31. Schneider M, Prudic K, Pippel A, Klapperstück M, Braam U, Müller CE, Schmalzing G, Markwardt F (2017) Interaction of purinergic P2X4 and P2X7 receptor subunits. Front Pharmacol 8:860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Csóka B, Németh ZH, Szabó I, Davies DL, Varga ZV, Pálóczi J, Falzoni S, Di Virgilio F, Muramatsu R, Yamashita T (2018) Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. JCI insight 3(11)

  33. Hofman P, Cherfils-Vicini J, Bazin M, Ilie M, Juhel T, Hébuterne X, Gilson E, Schmid-Allilana A, Boyer O, Adriouch S (2015) Genetic and pharmacological inactivation of the purinergic P2RX7 receptor dampens inflammation but increases tumor incidence in a mouse model of colitis-associated cancer. Cancer Res Canres 1778.2014

  34. Hechler B, Gachet C (2015) Purinergic receptors in thrombosis and inflammation. Arterioscler Thromb Vasc Biol 35(11):2307–2315

    Article  CAS  PubMed  Google Scholar 

  35. Khalid M, Manzoor S, Ahmad H, Asif A, Bangash TA, Latif A, Jaleel S (2018) Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor. Mol Biol Rep 1–6

  36. Huang C-F, Yeh M-L, Tsai P-C, Hsieh M-H, Yang H-L, Hsieh M-Y, Yang J-F, Lin Z-Y, Chen S-C, Wang L-Y (2014) Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. J Hepatol 61(1):67–74

    Article  CAS  PubMed  Google Scholar 

  37. Chitapanarux T, Phornphutkul K (2015) Risk factors for the development of hepatocellular carcinoma in Thailand. J Clin Transl Hepatol 3(3):182–188

    Article  PubMed  PubMed Central  Google Scholar 

  38. Künzli BM, Bernlochner M-I, Rath S, Käser S, Csizmadia E, Enjyoji K, Cowan P, d’Apice A, Dwyer K, Rosenberg R (2011) Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signalling 7(2):231–241

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Kim S-E, Paik HY, Yoon H, Lee JE, Kim N, Sung M-K (2015) Sex-and gender-specific disparities in colorectal cancer risk. World J Gastroenterol: WJG 21(17):5167–5175

    Article  PubMed  Google Scholar 

  40. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36(3):131–149

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are thankful to the Higher Education Commission and NUST for providing the opportunity to conduct this research work. We are also thankful to Liver Transplant Unit of Shaikh Zayd Hospital, Lahore, in coordinating this research work.

Author information

Author notes

  1. Both authors have contributed equally to this work.

Affiliations

  1. Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, H-12, Islamabad, 44000, Pakistan

    Arun Asif, Madiha Khalid & Sobia Manzoor

  2. Hepato-pancreatobiliary Liver Transplant Unit, Shaikh Zayd Hospital, Lahore, Punjab, 54000, Pakistan

    Hassam Ahmad

  3. Department of Histopathology, Shaikh Zayd Hospital, Lahore, Punjab, 54000, Pakistan

    Aman Ur Rehman

Authors
  1. Arun Asif
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madiha Khalid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sobia Manzoor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hassam Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aman Ur Rehman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sobia Manzoor.

Ethics declarations

The designed study was duly reviewed and approved by the ethics committee of Shaikh Zayd Hospital, Lahore, and Atta ur Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, in accordance with the recommendations of the World Medical Association’s Declaration of Helsinki for biomedical experimentation involving human subjects.

Conflict of interest

Arun Asif declares that he has no conflict of interest.

Madiha Khalid declares that she has no conflict of interest.

Sobia Manzoor declares that she has no conflict of interest.

Hassam Ahmad declares that he has no conflict of interest.

Aman-ur-Rehman declares that he has no conflict of interest.

Research involving human participants and/or animals

This article involved liver biopsy samples from human participants, and does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Asif, A., Khalid, M., Manzoor, S. et al. Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors. Purinergic Signalling 15, 367–374 (2019). https://doi.org/10.1007/s11302-019-09675-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11302-019-09675-0

Keywords

  • Inflammatory precursor
  • Purinergic signaling
  • Hepatocellular carcinoma
  • Cancer microenvironment